News

Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a ‘Functional Cure’ for Diabetes

PARTNERSHIP LEVERAGES IPSC-BASED BETA CELLS FROM EVOTEC'S QRBETA INITIATIVE COMBINED WITH SERNOVA'S PROPRIETARY IMPLANTABLE CELL POUCH™ DEVICETHE GOAL IS THE…

2 years ago

Scryb Wins Contract with Large Blockchain-Based Cryptocurrency Exchange for Licence to Cybeats Cybersecurity Enterprise Software Platform

Toronto, Ontario--(Newsfile Corp. - May 17, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company")…

2 years ago

VIVO Cannabis Announces First Quarter 2022 Results

Net revenue for Q1 2022 was $6.9 millionVIVO continues to pursue its international expansion strategy which now represents >50% of…

2 years ago

Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing…

2 years ago

cbdMD Announces Management Changes

Charlotte, North Carolina--(Newsfile Corp. - May 16, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the…

2 years ago

Perimeter Medical Imaging AI to Present at ROTH Canada Showcase Day

TORONTO & DALLAS--(BUSINESS WIRE)--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to…

2 years ago

Premier Geriatric Solutions PLLC Acquires Valley Family and Elder Care to Further Expand in Western Virginia

ROANOKE, VA / ACCESSWIRE / May 16, 2022 / Premier Geriatric Solutions PLLC (PGS), an innovative, rapidly expanding primary and…

2 years ago

Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities

Quarterly Net Revenue Increased 79% Year-Over-Year to $24.2 Million, the Highest Revenue in Company HistoryStrategic Priorities Focused on Driving Revenue…

2 years ago

Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates

Entered into $100 Million Private Placement AgreementFinalized pivotal Phase 3 trial design for gedatolisibReceived FDA Fast Track designation for gedatolisib…

2 years ago

Poko Innovations, Inc. Receives Validation and Authorization

TO SELL 44 CBD PRODUCTS IN THE UNITED KINGDOMUK Food Standards Agency (FSA) Validates Poko's ProductsUnder Novel Food ApplicationOnly FSA-Approved…

2 years ago